TMC435350-TiDP16-C101 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of Increasing Oral Doses of TMC435350 After Single and Repeated Dosing

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00938899
Recruitment Status : Completed
First Posted : July 14, 2009
Last Update Posted : May 19, 2011
Information provided by:
Tibotec Pharmaceuticals, Ireland